Etripamil

Products

Inquiry

Cat. No.: IBDI-436818

Etripamil (MSP-2017) is a short-acting L-type calcium-channel antagonist, can be used for the research of Paroxysmal Supraventricular Tachycardia (PSVT). Etripamil (MSP-2017) slows atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells.

Size (Solution): 10 mM * 1 mL in Ethanol

Size (Solid):

Product Details

Target	Calcium Channel
Molecular Weight	452.59
Appearance	Oil
Synonyms	MSP-2017, (-)-MSP-2017
SMILES	O=C(OC)C1=CC=CC(CCN(CCC[[email protected]](C2=CC=C(OC)C(OC)=C2)(C#N)C(C)C)C)=C1
Purity	98.80%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Pure form: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.